Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells
Abstract Targeted pharmacologic activation of antigen-specific (AgS) T cells may bypass limitations inherent in current T cell-based cancer therapies. We describe two immunotherapeutics platforms for selective delivery of costimulatory ligands and peptide-HLA (pHLA) to AgS T cells. We engineered and...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/897c1421d763409b9b5cd4b0353c9706 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:897c1421d763409b9b5cd4b0353c9706 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:897c1421d763409b9b5cd4b0353c97062021-12-02T18:51:15ZPeptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells10.1038/s41598-021-98716-z2045-2322https://doaj.org/article/897c1421d763409b9b5cd4b0353c97062021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98716-zhttps://doaj.org/toc/2045-2322Abstract Targeted pharmacologic activation of antigen-specific (AgS) T cells may bypass limitations inherent in current T cell-based cancer therapies. We describe two immunotherapeutics platforms for selective delivery of costimulatory ligands and peptide-HLA (pHLA) to AgS T cells. We engineered and deployed on these platforms an affinity-attenuated variant of interleukin-2, which selectively expands oligoclonal and polyfunctional AgS T cells in vitro and synergizes with CD80 signals for superior proliferation versus peptide stimulation.Ronald D. SeidelZohra MerazgaDharma Raj ThapaJonathan SorianoEmily SpauldingAhmet S. VakkasogluPaige RuthardtWynona BautistaSteven N. QuaylePeter A. KienerSimon LowJohn F. RossSaso CemerskiAnish SuriSteven C. AlmoRodolfo J. ChaparroNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Ronald D. Seidel Zohra Merazga Dharma Raj Thapa Jonathan Soriano Emily Spaulding Ahmet S. Vakkasoglu Paige Ruthardt Wynona Bautista Steven N. Quayle Peter A. Kiener Simon Low John F. Ross Saso Cemerski Anish Suri Steven C. Almo Rodolfo J. Chaparro Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells |
description |
Abstract Targeted pharmacologic activation of antigen-specific (AgS) T cells may bypass limitations inherent in current T cell-based cancer therapies. We describe two immunotherapeutics platforms for selective delivery of costimulatory ligands and peptide-HLA (pHLA) to AgS T cells. We engineered and deployed on these platforms an affinity-attenuated variant of interleukin-2, which selectively expands oligoclonal and polyfunctional AgS T cells in vitro and synergizes with CD80 signals for superior proliferation versus peptide stimulation. |
format |
article |
author |
Ronald D. Seidel Zohra Merazga Dharma Raj Thapa Jonathan Soriano Emily Spaulding Ahmet S. Vakkasoglu Paige Ruthardt Wynona Bautista Steven N. Quayle Peter A. Kiener Simon Low John F. Ross Saso Cemerski Anish Suri Steven C. Almo Rodolfo J. Chaparro |
author_facet |
Ronald D. Seidel Zohra Merazga Dharma Raj Thapa Jonathan Soriano Emily Spaulding Ahmet S. Vakkasoglu Paige Ruthardt Wynona Bautista Steven N. Quayle Peter A. Kiener Simon Low John F. Ross Saso Cemerski Anish Suri Steven C. Almo Rodolfo J. Chaparro |
author_sort |
Ronald D. Seidel |
title |
Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells |
title_short |
Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells |
title_full |
Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells |
title_fullStr |
Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells |
title_full_unstemmed |
Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells |
title_sort |
peptide-hla-based immunotherapeutics platforms for direct modulation of antigen-specific t cells |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/897c1421d763409b9b5cd4b0353c9706 |
work_keys_str_mv |
AT ronalddseidel peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT zohramerazga peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT dharmarajthapa peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT jonathansoriano peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT emilyspaulding peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT ahmetsvakkasoglu peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT paigeruthardt peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT wynonabautista peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT stevennquayle peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT peterakiener peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT simonlow peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT johnfross peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT sasocemerski peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT anishsuri peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT stevencalmo peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells AT rodolfojchaparro peptidehlabasedimmunotherapeuticsplatformsfordirectmodulationofantigenspecifictcells |
_version_ |
1718377458736037888 |